Patent classifications
C07D235/28
HETEROARYL-THIO-SUBSTITUTED PYRONES
A heteroaryl-thio-substituted pyrone compound that is a heteroaryl-thio-substituted pyrone or a heteroaryl-thio-substituted coumarin. In various embodiments, the heteroaryl-thio-substituted pyrone compound or a reaction product thereof is a metal corrosion inhibitor.
HETEROARYL-THIO-SUBSTITUTED PYRONES
A heteroaryl-thio-substituted pyrone compound that is a heteroaryl-thio-substituted pyrone or a heteroaryl-thio-substituted coumarin. In various embodiments, the heteroaryl-thio-substituted pyrone compound or a reaction product thereof is a metal corrosion inhibitor.
CANNABIGEROL DERIVATIVES AND USE THEREOF AS CANNABINOID RECEPTOR MODULATORS
The synthesis of a range of pentylbezene-1,3-diol compounds of formula I is disclosed. These compounds bind to cannabinoid 1 and 2 receptors (CB1 and CB2), and are thus presumed to be useful in modulating the activity of such receptors. Accordingly, the use of such synthetic cannabinoids in the treatment of various disorders mediated by CB1 and CB2 is contemplated.
CANNABIGEROL DERIVATIVES AND USE THEREOF AS CANNABINOID RECEPTOR MODULATORS
The synthesis of a range of pentylbezene-1,3-diol compounds of formula I is disclosed. These compounds bind to cannabinoid 1 and 2 receptors (CB1 and CB2), and are thus presumed to be useful in modulating the activity of such receptors. Accordingly, the use of such synthetic cannabinoids in the treatment of various disorders mediated by CB1 and CB2 is contemplated.
METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA
The present disclosure provides, in part, compositions, kits and methods for treating or preventing an influenza viral infection by administering a therapeutically effective amount of an inhibitor of influenza viral M mRNA nuclear export to a subject in need.
METHODS AND COMPOSITIONS FOR THE TREATMENT OF INFLUENZA
The present disclosure provides, in part, compositions, kits and methods for treating or preventing an influenza viral infection by administering a therapeutically effective amount of an inhibitor of influenza viral M mRNA nuclear export to a subject in need.
Thioether compounds as nitrification inhibitors
Provided herein are a use of thioether compounds of formula I as nitrification inhibitors, and agricultural mixtures and compositions including the thioether compounds.
Thioether compounds as nitrification inhibitors
Provided herein are a use of thioether compounds of formula I as nitrification inhibitors, and agricultural mixtures and compositions including the thioether compounds.
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
- Robert J. Altenbach ,
- Andrew Bogdan ,
- Sylvain Couty ,
- Nicolas Desroy ,
- Gregory A. Gfesser ,
- Christopher Gaëtan Housseman ,
- Philip R. Kym ,
- Bo Liu ,
- Thi Thu Trang Mai ,
- Karine Fabienne Malagu ,
- Nuria Merayo Merayo ,
- Olivier Laurent Picolet ,
- Mathieu Rafaël Pizzonero ,
- Xenia B. Searle ,
- Steven Emiel Van der Plas ,
- Xueqing Wang ,
- Ming C. Yeung
The invention discloses compounds of Formula (I),
##STR00001##
wherein A.sup.1, R.sup.1, R.sup.2, R.sup.3, R.sup.4, and n are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Modulators of the Cystic Fibrosis Transmembrane Conductance Regulator Protein and Methods of Use
- Robert J. Altenbach ,
- Andrew Bogdan ,
- Sylvain Couty ,
- Nicolas Desroy ,
- Gregory A. Gfesser ,
- Christopher Gaëtan Housseman ,
- Philip R. Kym ,
- Bo Liu ,
- Thi Thu Trang Mai ,
- Karine Fabienne Malagu ,
- Nuria Merayo Merayo ,
- Olivier Laurent Picolet ,
- Mathieu Rafaël Pizzonero ,
- Xenia B. Searle ,
- Steven Emiel Van der Plas ,
- Xueqing Wang ,
- Ming C. Yeung
The invention discloses compounds of Formula (I),
##STR00001##
wherein A.sup.1, R.sup.1, R.sup.2, R.sup.3, R.sup.4, and n are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.